Comparing access to orphan medicinal products in Europe

por Zamora, Bernarda, Maignen, Francois, O’Neill, Phill, Mestre-Ferrandiz, Jorge, Garau, Martina
Publicado 2019

Late translational research: putting forward a new model for developing new anti‐cancer treatments that addresses the needs of patients and society

por Lacombe, Denis, Bogaerts, Jan, Tombal, Bertrand, Maignen, François, Osipienko, Leeza, Sullivan, Richard, Golfinopoulos, Vassilis
Publicado 2019

Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

por Blagden, Sarah P., Yu, Ly-Mee, Ellis, Stephanie, Hughes, Helen, Shaaban, Abeer, Fennelly-Barnwell, Jonathan, Lythgoe, Mark P., Cooper, Alison M., Maignen, Francois M., Buckland, Sean W., Kearns, Pamela R., Brown, Louise C.
Publicado 2022

Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

por Blagden, Sarah P., Billingham, Lucinda, Brown, Louise C., Buckland, Sean W., Cooper, Alison M., Ellis, Stephanie, Fisher, Wendy, Hughes, Helen, Keatley, Debbie A., Maignen, Francois M., Morozov, Alex, Navaie, Will, Pearson, Sarah, Shaaban, Abeer, Wydenbach, Kirsty, Kearns, Pamela R.
Publicado 2020